Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide.

Liu BH, Jobichen C, Chia CSB, Chan THM, Tang JP, Chung TXY, Li J, Poulsen A, Hung AW, Koh-Stenta X, Tan YS, Verma CS, Tan HK, Wu CS, Li F, Hill J, Joy J, Yang H, Chai L, Sivaraman J, Tenen DG.

Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):E7119-E7128. doi: 10.1073/pnas.1801253115. Epub 2018 Jul 5.

PMID:
29976840
2.

Discovery and characterisation of the automethylation properties of PRDM9.

Koh-Stenta X, Poulsen A, Li R, Wee JL, Kwek PZ, Chew SY, Peng J, Wu L, Guccione E, Joy J, Hill J.

Biochem J. 2017 Mar 7;474(6):971-982. doi: 10.1042/BCJ20161067.

PMID:
28126738
3.

Identification of covalent active site inhibitors of dengue virus protease.

Koh-Stenta X, Joy J, Wang SF, Kwek PZ, Wee JL, Wan KF, Gayen S, Chen AS, Kang C, Lee MA, Poulsen A, Vasudevan SG, Hill J, Nacro K.

Drug Des Devel Ther. 2015 Dec 10;9:6389-99. doi: 10.2147/DDDT.S94207. eCollection 2015.

4.

Characterization of the histone methyltransferase PRDM9 using biochemical, biophysical and chemical biology techniques.

Koh-Stenta X, Joy J, Poulsen A, Li R, Tan Y, Shim Y, Min JH, Wu L, Ngo A, Peng J, Seetoh WG, Cao J, Wee JL, Kwek PZ, Hung A, Lakshmanan U, Flotow H, Guccione E, Hill J.

Biochem J. 2014 Jul 15;461(2):323-34. doi: 10.1042/BJ20140374.

PMID:
24785241

Supplemental Content

Loading ...
Support Center